We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BNOX Bionomics Ltd

0.0482 (3.65%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 165,466
Bid Price 1.35
Ask Price 1.79
News -
Share Name Share Symbol Market Stock Type
Bionomics Ltd BNOX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.0482 3.65% 1.3682 23:00:10
Open Price Low Price High Price Close Price Previous Close
1.33 1.33 1.45 1.40 1.32
Trades Shares Traded VWAP Financial Volume Average Volume
1,008 165,466  1.36  225,668 -
Last Trade Type Quantity Price Currency
18:50:23 82  1.35 USD

Bionomics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 11.30M - - - -35.48
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Bionomics

Date Time Source Heading
11/10/202316:11Dow Jones NewsADRs End Higher, Yoshitsu Co. Ltd. Climbs 19.2%
11/03/202305:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/18/202305:42Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private..
9/29/202306:29IH Market NewsFriday’s Wall Street Highlights: New Integrated, Nike,..
7/31/202305:00GlobeNewswire Inc.Quarterly Activities and Cashflow Report
7/28/202305:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/25/202305:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/24/202305:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/07/202308:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/07/202305:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
4/28/202305:00GlobeNewswire Inc.Quarterly Activities and Cashflow Report
2/23/202305:00GlobeNewswire Inc.Bionomics’ Half-Year Report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No BNOX Message Board. Create One! See More Posts on BNOX Message Board See More Message Board Posts

BNOX Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |